SCHEMBL1084362

SCHEMBL1084362

Oc1ccccc1-c1nc(N2CCC(N3CCC(O)CC3)CC2)c2cc(F)ccc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 1/20 0.51
CHEK2 O96017 4/20 0.51
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TSHR P16473 2/20 0.45
HIF1A Q16665 2/20 0.43
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OGFRL1 Q5TC84 1/20 0.41
PIK3CA P42336 3/20 0.40
MTOR P42345 1/20 0.40
SCN9A Q15858 1/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
PBRM1 Q86U86 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084784 0.92 SMAD3 (0.58) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084650 0.91 SMAD3 (0.57) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084082 0.89 CHEK2 (0.50) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084501 0.89 CHEK2 (0.50) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1621893 0.85 SMAD3 (0.56) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084686 0.84 MAPT (0.53) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL12721527 0.83 SMAD3 (0.73) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084207 0.83 SMAD3 (0.54) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1083975 0.82 SMAD3 (0.51) SMAD3CHEK2MEN1KMT2AALDH1A1
SCHEMBL1084602 0.82 SMAD3 (0.51) SMAD3CHEK2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed